Latest News & Events


A deal has been agreed. Read our analysis here.

The European Commission has published further guidance on the application of the Union's pharmaceutical acquis in markets historically dependent on medicines supply from or through Great Britain (N Ireland, Malta). This is the 'timed phased approach' or derogation. 

MHRA has published updated guidance on MAH and QPPV location for NI products from 1 January 2021. On 21 December MHRA published an updated FAQ

In light of the disruption following the closure of the French border, Steve Oldfield sent a letter to medicines suppliers on the National Supply Disruption Response

A draft unilateral declaration has been published by the European Union and the United Kingdom of Great Britain and Northern Ireland in the Withdrawal Agreement Joint Committee on human and veterinary medicines


Our regular webinars provide updates on government policy, guidance on preparing for potential changes and explain how these may affect businesses.

Next Webinar - 7 January

See our full events listing

View our previous Brexit webinars and briefings